Examining the Effects of Video-Assisted Discharge Education After Coronary Artery Bypass Graft Surgery on Patient Satisfaction and Anxiety

April 13, 2026 updated by: Nursena Birgin, Hasan Kalyoncu University
This study was conducted to examine the effects of standard and individualized video-assisted discharge education on patient satisfaction and anxiety levels following Coronary Artery Bypass Graft (CABG) surgery. Prior to the initiation of the study, ethical approval was obtained from Hasan Kalyoncu University and the relevant healthcare institutions. The study was carried out with a total of 120 patients who had undergone CABG surgery and were hospitalized in the Cardiovascular Surgery departments of Gaziantep Dr. Ersin Arslan Training and Research Hospital and Gaziantep City Hospital. The patients were randomly assigned into three groups: a control group, a standard video-assisted education group, and an individualized video-assisted education group. Data were collected using the Patient Information Form, the Patient Education Satisfaction Scale, and the State-Trait Anxiety Inventory (STAI). The data were analyzed using SPSS version

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Terminated

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Observational

Enrollment (Actual)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
120

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey (Türkiye)
    • Gaziantep
      • Gaziantep, Gaziantep, Turkey (Türkiye), 2700
        • Gaziantep City Hospital, Dr. Ersin Arslan Training and Research Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

A convenience sampling method was used. A total of 120 eligible patients who met the inclusion criteria and provided informed consent were enrolled in the study. Participants were randomly allocated into three parallel groups: standard video education, individualized video education, and control group.

Description

Inclusion Criteria:

  • Patients who have undergone coronary artery bypass graft (CABG) surgery
  • Age 18 years and older
  • Patients who are in the discharge phase and eligible to receive discharge education
  • Able to read and understand Turkish
  • Able to communicate effectively
  • Willing to participate in the study and provide written informed consent

Exclusion Criteria:

  • Diagnosis of severe psychiatric disorder
  • Presence of cognitive impairment or dementia
  • Visual or hearing impairment that would prevent participation in the education program
  • Development of major postoperative complications requiring intensive care
  • Patients who are not clinically stable at the time of discharge
  • Patients who withdraw from the study during the research process

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort

Group / Cohort

A group or subgroup of participants in an observational study that is assessed for biomedical or health outcomes.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
SVG
standard video group
Behavioral: video discharge education
On the day of discharge, patients in the cardiovascular surgery unit were informed about the study, and their written informed consent was obtained. Before the educational intervention, patients were asked to complete the introductory information form and the State-Trait Anxiety Inventory (STAI). On the same day, routine discharge education was provided by the clinical nurse, and patients' questions were addressed following the session.In addition, a standardized video prepared by the researcher was sent to the patients' mobile phones via text message on the day of discharge. Patients were asked to watch the video, and any questions they had were answered after viewing. They were also informed that they could rewatch the video after discharge whenever they needed to recall the information provided during the education.
iVG
individual video group
Behavioral: individual video discharge training
On the day of discharge, patients were informed about the study and their written informed consent was obtained. Prior to the educational intervention, the state and trait anxiety levels of the patients in the individualized video group were assessed. To enable patients to access the educational content after discharge, a pre-recorded video prepared by the researcher was sent to their mobile phones via text message. Patients were asked to watch the video, and the researcher remained with them during viewing to answer any potential questions.Information not included in the standard video-such as patients' chronic conditions and medications to be used after discharge-was provided verbally. These individualized instructions were also recorded as a video. The video containing personalized information was then sent to the patients' mobile phones via text message. After all questions were addressed, patients' state anxiety levels and satisfaction with patient education were evaluated
CG
control grubu
Behavioral: discharge education
On the day of discharge, patients in the control group were informed about the study, and written informed consent was obtained. Prior to the educational intervention, patients' state and trait anxiety levels were assessed. The data collection form was administered, and patients were asked to complete the questionnaire.Patients in the control group received routine verbal discharge education in accordance with standard clinical practice. Following the education, patients' questions were addressed. Subsequently, their state anxiety levels and satisfaction with patient education were assessed. The data collection form was re-administered, and patients were asked to complete the questionnaire again. Completion of the questionnaires took approximately 15-20 minutes.

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Patient Education Satisfaction Scale Total Score
Time Frame: Baseline" or "Day 1"
Patient satisfaction will be assessed using the Patient Education Satisfaction Scale, a 30-item Likert-type scale. Each item is scored from 1 to 5, and total scores range from 30 to 150. Higher scores indicate higher satisfaction with discharge education.
Baseline" or "Day 1"
State Anxiety Score (State-Trait Anxiety Inventory - STAI-State)
Time Frame: Baseline" or "Day 1"
State anxiety levels will be measured using the State-Trait Anxiety Inventory (STAI-State). Scores range from 20 to 80, with higher scores indicating higher levels of anxiety
Baseline" or "Day 1"

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Hasan Kalyoncu University

Investigators

Investigators

A researcher involved in a clinical study. Related terms include site principal investigator, site sub-investigator, study chair, study director, and study principal investigator.
  • Principal Investigator: Nursena Birgin, expert, Hasan Kalyoncu University
  • Study Director: aynur koyuncu, associate professor, Hasan Kalyoncu University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
September 8, 2023

Primary Completion (Actual)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
February 29, 2024

Study Completion (Actual)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
February 29, 2024

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
March 8, 2026

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
April 7, 2026

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
April 14, 2026

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
April 16, 2026

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
April 13, 2026

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
April 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • 13.04.2023 -008

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Age BMI Gender Marital Status Education Level Employment Status People Living With Place of Residence History of Previous Surgery Smoking Status Alcohol Use Status Presence of Chronic Diseases

IPD Sharing Access Criteria

Researchers in the field of surgical nursing

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF
  • CSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings